Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$57.72 - $65.01 $4,155 - $4,680
-72 Reduced 7.25%
921 $57,000
Q1 2022

May 03, 2022

SELL
$57.92 - $72.58 $347 - $435
-6 Reduced 0.6%
993 $59,000
Q4 2021

Feb 10, 2022

BUY
$64.88 - $73.64 $5,060 - $5,743
78 Added 8.47%
999 $73,000
Q1 2021

May 28, 2021

BUY
$60.0 - $68.46 $55,260 - $63,051
921 New
921 $59,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sierra Capital LLC Portfolio

Follow Sierra Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sierra Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sierra Capital LLC with notifications on news.